Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 5/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tonabersat SCHEMBL15973365 | 1.00 | ABCC9 (0.54) | ABCC9 | |
| Tonabersat SCHEMBL29717099 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| Tonabersat SCHEMBL260661 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| Tonabersat SCHEMBL29373962 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| Tonabersat SCHEMBL7169677 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| Tonabersat SCHEMBL5917016 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| Tonabersat SCHEMBL29377931 | 0.93 | ABCC9 (0.62) | ABCC9 | |
| SCHEMBL15546692 | 0.83 | ABCC9 (0.48) | ABCC9 | |
| SCHEMBL15546693 | 0.83 | ABCC9 (0.48) | ABCC9 | |
| SCHEMBL7044135 | 0.82 | ABCC9 (0.59) | ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4677087-A1 | NOVEL TREATMENTS FOR OCULAR DISORDERS | Glaukos Corporation (US) | 2026-01-14 | — | — | EP | disclosed |
| CN-119300817-A | Compositions and methods for modulating epithelial-mesenchymal transition | 奥克兰联合服务有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024187046-A1 | NOVEL TREATMENTS FOR OCULAR DISORDERS | AMBER OPHTHALMICS, INC. (US) | 2024-09-12 | — | — | WO | disclosed |
| EP-4301381-A1 | COMPOSITIONS AND METHODS FOR MODULATING EPITHELIAL-MESENCHYMAL TRANSITION | Auckland Uniservices Limited (NZ) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022187387-A9 | COMPOSITIONS AND METHODS FOR MODULATING EPITHELIAL-MESENCHYMAL TRANSITION | AUCKLAND UNISERVICES LIMITED (NZ) | 2023-10-05 | — | — | WO | disclosed |
| WO-2022187387-A1 | COMPOSITIONS AND METHODS FOR MODULATING EPITHELIAL-MESENCHYMAL TRANSITION | AUCKLAND UNISERVICES LIMITED (NZ) | 2022-09-09 | — | — | WO | disclosed |
| EP-4027992-A1 | COMPOSITIONS AND METHODS FOR RESCUING RETINAL AND CHOROIDAL STRUCTURE AND FUNCTION | Auckland Uniservices Limited (NZ) | 2022-07-20 | — | — | EP | disclosed |
| CN-114727981-A | Compositions and methods for rescuing retinal and choroidal structures and functions | 奥克兰联合服务有限公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-3958886-A1 | COMPOSITIONS AND METHODS FOR PROTECTING EPITHELIAL AND BARRIER INTEGRITY | Ocunexus Therapeutics, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| CN-114010788-A | Channel modulators | 奥克兰联合服务有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114025786-A | Compositions and methods for protecting epithelial and barrier integrity | 欧耐柯萨斯医疗有限公司 | 2022-02-08 | — | — | CN | disclosed |